27.01.2021

Octenisept or Miramistin, which is more effective

Simultaneous use is impractical, since the effect of exposure to the affected area is identical.

Miramistin is best used to disinfect skin and mucous membranes. It is effective for cleansing the throat and instillation of the nasal cavity. It can be used for inhalation with ENT diseases.

Octenisept can also be used in these cases, but, for example, for the treatment of tonsillitis, it must be diluted with water 1: 6. The drug is more used to treat fungal diseases.

According to patients, Miramistin has a more neutral taste, and its analogue is bitter. Octenisept is allowed to be used in the treatment of children, but the child can involuntarily swallow the liquid, which should not be allowed according to the instructions.

We can conclude that Miramistin wins in many respects. But the decision about the choice of antiseptic lies with the attending physician and patient.

To cleanse a wound, tissue, organ from harmful microorganisms, you can not do without chemicals called antiseptics. Some have long established themselves as effective remedies, while others are only entering the arena of the modern drug market. For example, Octenisept is a new generation drug, and Miramistin is a tool already familiar to many. There comes a time when you need to choose one of them, for this you need to know the pros and cons of each.

Octenisept

Combined antiseptic and disinfectant. It is produced in the form of a solution of 250 ml, 50 ml. Vials can be with nebulizers or vaginal applicators. The main active ingredients are octenidine hydrochloride and 2-phenoxyethanol.

Octenisept

The drug is used to disinfect mucous membranes, skin tissues, wounds. It has a bactericidal, fungicidal effect. The tool is active against:

  • Lipophilic viruses: herpes virus, HIV, hepatitis B virus.
  • Gram-positive bacteria (in combination with 1% albumin).
  • Gram-negative bacteria (in combination with 1% albumin).
  • Yeast (in combination with 1% albumin).
  • Fungi (in combination with 1% albumin).

Octenisept is used in the treatment of children, premature infants. If necessary, during pregnancy. The drug acts locally. Does not penetrate the mucous membranes and skin, the placenta. However, it can not be injected deep into the tissue, for example, using a syringe so as not to infect the tissue. It is better to use a swab or spray.

When processing mucous membranes, it is necessary to avoid swallowing the substance. It is important to ensure that it does not get into your eyes.

There are no cases of overdose. The drug causes adverse reactions:

  • Rarely: sensation of temperature increase at the site of application, hyperemia of the site, burning sensation at the site of application.
  • Very rare: allergic reactions.
  • Edema, erythema, necrosis, pain, blisters, eczema.
  • Bitter aftertaste in mouth.

The drug is not used simultaneously with PVP-iodine.

Miramistin

The drug belongs to antiseptic and disinfectants. It is produced in the form of a solution of 0.01% and ointment 5 mg / g. It is applied only externally. The main active ingredient is miramistin (0.1 mg / 1 ml).

Miramistin

A feature of an antiseptic is that it acts oppressively selectively on harmful microorganisms without harming the membranes and cells of the human body. It has a pronounced antibacterial effect on bacteria:

  1. Gram-positive.
  2. Gram-negative.
  3. Anaerobic.
  4. Aerobic
  5. Spore-forming.
  6. Asporogenous.

The drug is active against monoculture and microbial colonies, including Hospital strains.

Its effect extends to the causative agents of sexually transmitted infections:

  • Gonococcus
  • Chlamydia
  • Trichomonas.
  • Treponema pallidum.
  • Herpes virus.

It has an antifungal effect, spreads to: yeast, yeast-like fungi, dermatophytes, pathogenic fungi. Under the influence of the drug, the resistance of mycobacteria to antibiotics is significantly reduced.

After applying the drug to the lesion, the main substance does not penetrate the skin and mucous structures.

Miramistin is not used in pediatrics. No cases of overdose have been reported. Side effects are rare. Manifested in the form of a short-term burning sensation. Usually these symptoms disappear on their own after 15 seconds. On the skin, slight irritation, redness, and itching may appear.
General characteristics of drugs

Being antiseptics, both drugs act on a wide range of microorganisms. Accordingly, they have similar indications:

Miramistin Octenisept
Infected wounds of various localization, etiology Diagnostic and surgical procedures in the anogenital area: vagina, glans penis, vulva
Secondary infections of healing wounds; prevention Bladder catarrhal (flushing)
Burns 1 and 2 A degrees; preparatory procedures before dermoplasty Oral infections
Purulent postpartum wounds; postpartum vaginal / perineal infections; vulvovaginitis Bacterial, fungal infections of the genitals
Candidiasis, mycoses (complex treatment) Mycoses
Sexually transmitted diseases: herpes, gonorrhea, syphilis Wounds
ENT diseases: otitis media, tonsillitis, sinusitis Burns of various origins
Oral diseases: periodontitis, stomatitis,

Both drugs are available in the form of solutions and are used only topically.

What is the difference

Despite the fact that the drugs act on the same principle, they have certain differences:

  1. Octenisept is a new generation drug and is an analogue of Miramistin.
  2. Octenisept has a combined composition, and Miramistin contains one substance.
  3. The main substances are completely different in structure.
  4. Octenisept is indicated for children from the first days of life, and Miramistin is contraindicated in the children’s category of patients.
  5. Miromistin costs from 187-213 rubles, and Octenisept – 376 rubles.

Octenisept has more contraindications: hypersensitivity to constituent substances; postoperative treatment of the tympanic membrane, instillation of the bladder. Miramistin – hypersensitivity to the main component.

Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *